ZA200005369B - Calcilytic compounds. - Google Patents

Calcilytic compounds.

Info

Publication number: ZA200005369B
Authority: ZA; South Africa
Prior art keywords: calcilytic compounds; calcilytic; compounds
Prior art date: 1998-04-08

Application number

ZA200005369A

Other languages

English (en)

Inventor

Bhatnagar Pradip Kumar

Burgess Joelle Lorraine

Callahan James Francis

Calvo Raul Rolando

Mar Eric G Del

Lago Maria Amparo

Thomas T Nguyen

Original Assignee

Smithkline Beecham Corp

Nps Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-08

Filing date

1999-04-08

Publication date

2001-12-18

1999-04-08 Application filed by Smithkline Beecham Corp, Nps Pharma Inc filed Critical Smithkline Beecham Corp

2001-12-18 Publication of ZA200005369B publication Critical patent/ZA200005369B/xx

Links

230000001126 calcilytic effect Effects 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/33—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring with cyano groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/22—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by carbon atoms having at least two bonds to oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/37—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by etherified hydroxy groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/06—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by carboxyl groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Diabetes (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

ZA200005369A 1998-04-08 1999-04-08 Calcilytic compounds. ZA200005369B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US8109398P	1998-04-08	1998-04-08

Publications (1)

Publication Number	Publication Date
ZA200005369B true ZA200005369B (en)	2001-12-18

Family

ID=22162059

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200005369A ZA200005369B (en)	1998-04-08	1999-04-08	Calcilytic compounds.

Country Status (33)

Country	Link
US (1)	US6395919B1 (de)
EP (1)	EP1070048B1 (de)
JP (1)	JP2002510671A (de)
KR (1)	KR20010042526A (de)
CN (1)	CN1304401A (de)
AP (1)	AP1271A (de)
AR (1)	AR018177A1 (de)
AT (1)	ATE303358T1 (de)
AU (1)	AU752389B2 (de)
BG (1)	BG104916A (de)
BR (1)	BR9909486A (de)
CA (1)	CA2327279A1 (de)
CO (1)	CO5031246A1 (de)
DE (1)	DE69927008T2 (de)
DZ (1)	DZ2751A1 (de)
EA (1)	EA200001039A1 (de)
EG (1)	EG24178A (de)
ES (1)	ES2247795T3 (de)
HU (1)	HUP0101346A3 (de)
ID (1)	ID27004A (de)
IL (1)	IL138918A0 (de)
MX (1)	MXPA00009844A (de)
MY (1)	MY121054A (de)
NO (1)	NO20005006L (de)
NZ (1)	NZ507288A (de)
OA (1)	OA11499A (de)
PE (1)	PE20000415A1 (de)
PL (1)	PL343357A1 (de)
SK (1)	SK14852000A3 (de)
TR (1)	TR200002896T2 (de)
UA (1)	UA58586C2 (de)
WO (1)	WO1999051569A1 (de)
ZA (1)	ZA200005369B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ECSP003590A (es) *	1999-07-31	2002-02-25	Smithkline Beecham Corp	Compuestos calcioliticos
US20030018203A1 (en) *	2002-07-17	2003-01-23	Largo Maria Amparo	Calcilytic compounds
MY159417A (en) *	2000-01-24	2017-01-13	Smithkline Beecham Corp	Calcilytic compounds
FR2812875B1 (fr)	2000-08-08	2003-12-12	Centre Nat Rech Scient	Nouvelles diamines possedant une activite modulatrice des casr et leur mode de preparation
EP1308436B1 (de) *	2000-08-11	2008-10-15	Japan Tobacco Inc.	Calciumrezeptor-antagonisten
JP2004514659A (ja) *	2000-10-25	2004-05-20	スミスクライン・ビーチャム・コーポレイション	カルシライティック化合物
MY143244A (en) *	2002-11-26	2011-04-15	Smithkline Beecham Corp	Calcilytic compounds
WO2004069793A2 (en)	2003-01-28	2004-08-19	Bristol-Myers Squibb Company	Novel 2-substituted cyclic amines as calcium sensing receptor modulators
US7205322B2 (en)	2003-02-12	2007-04-17	Bristol-Myers Squibb Company	Thiazolidine compounds as calcium sensing receptor modulators
EP1619180B1 (de)	2003-04-23	2009-12-16	Japan Tobacco Inc.	CaSR-ANTAGONIST
WO2004106280A1 (ja)	2003-05-28	2004-12-09	Japan Tobacco Inc.	ＣａＳＲアンタゴニスト
US7265145B2 (en)	2003-05-28	2007-09-04	Bristol-Myers Squibb Company	Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method
WO2005077886A1 (en) *	2004-02-06	2005-08-25	Smithkline Beecham Corporation	Calcilytic compounds
US7531518B2 (en) *	2004-05-14	2009-05-12	Unigene Laboratories Inc.	Method for fostering bone formation and preservation
US7648965B2 (en)	2004-05-14	2010-01-19	Unigene Laboratories Inc.	Method for fostering bone formation and preservation
US20060293667A1 (en) *	2005-05-19	2006-12-28	Agnes Vignery	Bone implant device and methods of using same
AU2006285080B2 (en) *	2005-09-02	2012-05-03	Amgen Inc.	Methods of modulating intestinal fluid balance
EP2139462B1 (de) *	2007-03-30	2014-01-22	Amgen Inc.	Calcimimetische verbindungen zur verwendung bei der behandlung von darmerkrankungen
CN102307847A (zh) *	2008-12-24	2012-01-04	第一三共株式会社	茚满基化合物
WO2010103429A1 (en)	2009-03-10	2010-09-16	Pfizer Inc.	1,1-(Dimethyl-Ethylamino)-2-Hydroxy-Propoxy]-Ethyl}-3-Methyl-Biphenyl-4- Carboxylic Acid Derivatives As Calcium Receptor Antagonists
GB201217330D0 (en)	2012-09-28	2012-11-14	Univ Cardiff	Therapeutic for treating inflammatory lung disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2533210A1 (fr) *	1982-09-17	1984-03-23	Lyon I Universite Claude	Edulcorants de synthese
DE3301198A1 (de) *	1983-01-15	1984-07-19	Hoechst Ag, 6230 Frankfurt	N-arylalkylamin-3-propoxypyridin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische praeparate und deren verwendung
US5541204A (en) *	1994-12-02	1996-07-30	Bristol-Myers Squibb Company	Aryloxypropanolamine β 3 adrenergic agonists
TR199800521T1 (xx)	1995-09-21	1998-06-22	Eli Lilly And Company	Se�imli beta3 adrenerjik agonistler.
WO1997037967A1 (en) *	1996-04-09	1997-10-16	Nps Pharmaceuticals, Inc.	Calcilytic compounds

1999
- 1999-04-06 MY MYPI99001327A patent/MY121054A/en unknown
- 1999-04-06 AR ARP990101554A patent/AR018177A1/es unknown
- 1999-04-06 PE PE1999000275A patent/PE20000415A1/es not_active Application Discontinuation
- 1999-04-07 EG EG36999A patent/EG24178A/xx active
- 1999-04-07 DZ DZ990052A patent/DZ2751A1/xx active
- 1999-04-08 AU AU34819/99A patent/AU752389B2/en not_active Ceased
- 1999-04-08 WO PCT/US1999/007722 patent/WO1999051569A1/en not_active Ceased
- 1999-04-08 TR TR2000/02896T patent/TR200002896T2/xx unknown
- 1999-04-08 SK SK1485-2000A patent/SK14852000A3/sk unknown
- 1999-04-08 DE DE69927008T patent/DE69927008T2/de not_active Expired - Lifetime
- 1999-04-08 AP APAP/P/2000/001931A patent/AP1271A/en active
- 1999-04-08 HU HU0101346A patent/HUP0101346A3/hu unknown
- 1999-04-08 KR KR1020007011166A patent/KR20010042526A/ko not_active Ceased
- 1999-04-08 CO CO99020604A patent/CO5031246A1/es unknown
- 1999-04-08 ZA ZA200005369A patent/ZA200005369B/xx unknown
- 1999-04-08 PL PL99343357A patent/PL343357A1/xx not_active Application Discontinuation
- 1999-04-08 EP EP99916516A patent/EP1070048B1/de not_active Expired - Lifetime
- 1999-04-08 BR BR9909486-0A patent/BR9909486A/pt not_active Application Discontinuation
- 1999-04-08 NZ NZ507288A patent/NZ507288A/en not_active IP Right Cessation
- 1999-04-08 JP JP2000542291A patent/JP2002510671A/ja not_active Withdrawn
- 1999-04-08 CA CA002327279A patent/CA2327279A1/en not_active Abandoned
- 1999-04-08 ID IDW20002001A patent/ID27004A/id unknown
- 1999-04-08 AT AT99916516T patent/ATE303358T1/de not_active IP Right Cessation
- 1999-04-08 CN CN99807083A patent/CN1304401A/zh active Pending
- 1999-04-08 IL IL13891899A patent/IL138918A0/xx unknown
- 1999-04-08 ES ES99916516T patent/ES2247795T3/es not_active Expired - Lifetime
- 1999-04-08 MX MXPA00009844A patent/MXPA00009844A/es unknown
- 1999-04-08 US US09/647,793 patent/US6395919B1/en not_active Expired - Lifetime
- 1999-04-08 EA EA200001039A patent/EA200001039A1/ru unknown
- 1999-08-04 UA UA2000105670A patent/UA58586C2/uk unknown
2000
- 2000-10-04 NO NO20005006A patent/NO20005006L/no not_active Application Discontinuation
- 2000-10-06 OA OA1200000277A patent/OA11499A/en unknown
- 2000-11-07 BG BG104916A patent/BG104916A/xx unknown

Also Published As

Publication number	Publication date
EA200001039A1 (ru)	2001-04-23
JP2002510671A (ja)	2002-04-09
AU3481999A (en)	1999-10-25
NO20005006D0 (no)	2000-10-04
MXPA00009844A (es)	2003-07-14
EP1070048A1 (de)	2001-01-24
AP1271A (en)	2004-04-21
HK1034243A1 (en)	2001-10-19
BR9909486A (pt)	2001-11-06
AU752389B2 (en)	2002-09-19
NO20005006L (no)	2000-10-04
CN1304401A (zh)	2001-07-18
PL343357A1 (en)	2001-08-13
EP1070048B1 (de)	2005-08-31
ID27004A (id)	2001-02-22
DZ2751A1 (fr)	2003-09-15
AR018177A1 (es)	2001-10-31
ES2247795T3 (es)	2006-03-01
EP1070048A4 (de)	2001-11-07
ATE303358T1 (de)	2005-09-15
EG24178A (en)	2008-09-28
DE69927008D1 (de)	2005-10-06
BG104916A (en)	2001-06-29
WO1999051569A1 (en)	1999-10-14
MY121054A (en)	2005-12-30
OA11499A (en)	2004-05-05
IL138918A0 (en)	2001-11-25
TR200002896T2 (tr)	2001-01-22
HUP0101346A3 (en)	2003-03-28
DE69927008T2 (de)	2006-03-16
KR20010042526A (ko)	2001-05-25
US6395919B1 (en)	2002-05-28
SK14852000A3 (sk)	2001-05-10
HUP0101346A2 (hu)	2001-08-28
PE20000415A1 (es)	2000-05-21
UA58586C2 (uk)	2003-08-15
CO5031246A1 (es)	2001-04-27
CA2327279A1 (en)	1999-10-14
NZ507288A (en)	2003-05-30
AP2000001931A0 (en)	2000-09-30

Publication	Publication Date	Title
EG24814A (en)	2010-09-21	Novel compounds.
DE69941083D1 (en)	2009-08-20	12,13-cyclopropan-epothilonderivate
ZA996185B (en)	2000-04-10	Sulfanylsilanes.
ZA200005136B (en)	2001-03-02	Dihydropyrimides.
ZA995673B (en)	2000-03-30	Fungicidal trifluoromethylalkylamino-triazolopyrimidines.
IL132205A0 (en)	2001-03-19	Calcilytic compounds
ZA991272B (en)	1999-08-18	Novel thiobenzamides.
EG24178A (en)	2008-09-28	Calcilytic compounds
ZA200108968B (en)	2003-09-05	New compounds.
EP1104411A4 (de)	2002-10-24	Calcylytische verbindungen
ZA992443B (en)	1999-10-01	Hydroxy-methyl-hexanones.
ZA991841B (en)	1999-09-08	Chemical Compounds.
IL144470A0 (en)	2002-05-23	Calcilytic compounds
ZA994085B (en)	2000-12-21	Compound liquor.
ZA200200784B (en)	2003-01-29	Calcilytic compounds.
ZA992899B (en)	2000-03-29	Novel compound.
ZA993123B (en)	1999-11-08	Trisresorcinyltriazines.
ZA9811503B (en)	2000-06-15	Novel compounds.
ZA9811758B (en)	2000-06-22	Novel compounds.
ZA995325B (en)	2000-02-22	Methylcyclotetradec-5-en-1-ones.
MXPA03000556A (es)	2003-06-06	Compuestos calciliticos.
ZA200303082B (en)	2004-04-28	Calcilytic compounds.
ZA991032B (en)	1999-10-27	Chemical compounds.
EP1112073A4 (de)	2002-10-25	Calcilytische verbindungen
ZA991761B (en)	1999-09-06	New agent.